Medline to acquire Asid Bonz

Medline International, a manufacturer and distributor of healthcare supplies in Europe and Medi-Globe Group, has entered into a definitive agreement to acquire 100% of shares of Asid Bonz, a German supplier of medical devices, from Medi-Globe Group.

Asid Bonz is a supplier to hospitals in Germany, offering surgery, anaesthesia, ward-supply and urology products. Asid Bonz was founded in 1811 and is known for the development of the first anaesthetic ether. In 2021, Asid Bonz recorded over €30 million in revenues and served over 1,100 hospitals in Germany.

Medline will make the Asid Bonz brand available outside of Germany to its broad European customer base. Within Germany, the Asid Bonz sales force will have access to Medline products to strengthen their partnership with customers.

Tripp Amdur, Medline Europe Group president, said: “We are excited to increase our product offering and work with this award-winning organisation with a renowned customer focus. Medline is a relatively new player in urology and anaesthesia. This acquisition grows our presence in these areas of the hospital. Asid Bonz’s employees, products and service have a long-standing and trusted reputation and this combination will enable us to better meet the needs of our healthcare customers and become a more valued partner.”

Martin Lehner, CEO of Medi-Globe Group, added: “Asid Bonz is known for its unwavering commitment to its customers, providing high-quality medical products that are used to treat patients every day. We are sure that under the ownership of Medline, Asid Bonz will provide substantial avenues of growth in the future. The sale sharpens Medi-Globe’s focus on our core business, which is the development and marketing of innovative single-use solutions for minimally invasive clinical therapies.”